Roos, Izanne; Sharmin, Sifat; Horakova, Dana; Kubala-Havrdova, Eva; Libertinova, Jana; Vachova, Marta; Alroughani, Raed; Boz, Cavit; Rous, Zuzana; Buzzard, Katherine; Skibina, Olga; Peterka, Marek; Hradilek, Pavel; Mares, Miroslav; Coles, Alasdair; Brown, J-William-L; Eichau-Madueno, Sara; Foschi, Matteo; Prevost, Julie; Terzi, Murat; Prat, Alexandre; Girard, Marc; Meca-Lallana, José-Eustasio; John, Nevin; Blanco, Yolanda; van-der-Walt, Anneke; Butzkueven, Helmut; Recmanova, Eva; Laureys, Guy; Ampapa, Radek; Macdonell, Richard; Pavelek, Zbysek; Khoury, Samia-J; D'Amico, Emanuele; Gerlach, Oliver; Van-Pesch, Vincent; Maimone, Davide; Romero-Ferrando, Beatriz; McCombe, Pamela; Mrabet, Saloua; Willekens, Barbara; Cardenas-Robledo, Simón; Ramo-Tello, Cristina; Stourac, Pavel; Houskova, Jana; Shaygannejad, Vahid; Hodgkinson, Suzanne; Cartechini, Elisabetta; Kermode, Allan-G; Fabis-Pedrini, Marzena; Carroll, William-M; Slee, Mark; Sánchez-Menoyo, José-Luis; Al-Asmi, Abdullah; Mathey, Guillaume; Giannesini, Claire; Michel, Laure; Ciron, Jonathan; de-Seze, Jerome; Ruet, Aurelie; Kwiatkowski, Arnaud; Zephir, Helene; Papeix, Caroline; Lebrun-Frenay, Christine; Moreau, Thibault; Berger, Eric; Clavelou, Pierre; Pelletier, Jean; Casez, Olivier; Bourre, Bertrand; Wahab, Abir; Magy, Laurent; Camdessanche, Jean-Philippe; Doghri, Ines; Tchikviladze, Maia; Sellebjerg, Finn; Romme-Christensen, Jeppe; Jensen, Henrik-Boye; Illes, Zsolt; Bramow, Stephan; Rasmussen, Peter; Stilund, Morten-Leif; Schafer, Jakob; Kant, Matthias; Weglewski, Arkadiusz; Vukusic, Sandra; Magyari, Melinda; Laplaud, David-Axel; Kalincik, Tomas
(BMJ PUBLISHING GROUP, 2026-05-20)
BACKGROUND: Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, is a high-efficacy therapy for multiple sclerosis (MS). METHODS: Patients with relapse-onset MS treated with ocrelizumab, fingolimod, natalizumab or ...